Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol in Rheumatoid Arthritis
NCT07089381Recruiting
- Sponsor
- Ain Shams University
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by Ain Shams University. Primary endpoints: Serum Sirtuin 1 at 6 months, Serum Myeloperoxidase at 6 months and 1 more. Started Aug 2025; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07089381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07089381.